Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type 2 diabetes. But as their popularity grows, so do questions about ...

Higher protein intake may be protective against muscle loss, which is tied to less improvement in glucose homeostasis.

THURSDAY, July 17, 2025 (HealthDay News) -- Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost fitness and can cause serious muscle loss, potentially undermining the long ...

Could One of These Drugs Be the Next Ozempic? With dozens of drugs in development, semaglutide and tirzepatide may only be the beginning of next-generation diabetes and weight loss treatments.

Experts explain why protein is crucial for anyone on weight-loss drugs—and how to get enough to protect your muscle and metabolism.

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published ...

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and ...